Rapid2 Therapy System

Magstim’s Rapid2 Therapy System is an FDA-cleared, non-invasive device for people suffering from treatment-resistant Major Depressive Disorder (MDD).

Born from 30 years of leading research, Magstim’s Transcranial Magnetic Stimulation (TMS) expertise provides clinicians with a revolutionary treatment. The significant majority of TMS research studies cite the use of Magstim’s pioneering products.

A safe and effective non-drug based treatment for depression
TMS therapy delivers repetitive magnetic pulses, designed to stimulate the left dorsolateral prefrontal cortex, the area of the brain associated with the regulation of mood. This non-invasive outpatient procedure provides a proven treatment option for those who have failed to respond to antidepressants or those unable to undergo medication.